Khan, Mansoor individual record
Professor and Vice Dean

Dr. Mansoor A. Khan serves as a professor and Vice Dean of the Texas A&M University Rangel College of Pharmacy at College Station, Texas. Prior to joining Texas A&M in 2015, he served as the Director of Product Quality Research and a Senior Biomedical Research Scientist (SBRS) at CDER in US Food and Drug Administration for over eleven years. In FDA, he led the research and review teams to promote manufacturing science, and served as a founding member of the FDA Emerging Technology Team. Dr. Khan received his Ph.D. degree in industrial pharmacy form St. Johns University in NY. He has published over 335 peer-reviewed manuscripts in pharmaceutical formulations and manufacturing sciences, and delivered over 300 presentations world-wide. Dr. Khan's research, currently supported by the NIH and FDA, spans drug delivery and formulations, and he has received over ten million dollars in funding as a principal investigator.

Dr. Khan has held leadership positions at the AAPS including elected chair of formulations design and development (FDD) section. He serves on the editorial board of Pharmaceutical Technology, International Journal of Pharmaceutics, AAPSPharmsciTech, and the Drug Delivery and Translational Research. He has received about 20 FDA/CDER review, research, and exemplary achievement awards, outstanding alumni award at St. Johns University College of Pharmacy, Excellence Award in Texas A&M University. He received the 2012 AAPS Research Achievement Award in Formulations Design and Development. He is also an AAPS and AAiPS Fellow. Dr. Khan served as FDA representative to the World Health Organization (WHO), United States Pharmacopoeia (USP), European Medicine Agency (EMA), DARPA, NIH, National Institute of Pharmaceutical Technology and Education (NIPTE), and International Pharmaceutical Federation (FIP). He is also a member of the European Union Academy of Sciences.

education and training
selected publications
Academic Articles221
  • Doke, M., Kashanchi, F., Khan, M. A., & Samikkannu, T. (2021). HIV-1 Tat and cocaine impact astrocytic energy reservoir influence on miRNA epigenetic regulation. Genomics. 113(6), 3461-3475.
    doi badge
  • Khuroo, T., Mohamed, E. M., Dharani, S., Afrooz, H., Barakh Ali, S. F., Cook, P., Khan, M. A., & Rahman, Z. (2021). Coating characterization by hyperspectroscopy and predictive dissolution models of tablets coated with blends of cellulose acetate and cellulose acetate phthalate.. AAPS PharmSciTech. 22(3), 122.
    doi badge pubmed badge
  • Khuroo, T., Dharani, S., Mohamed, E. M., Immadi, S., Wu, Z., Khan, M. A., ... Rahman, Z. (2021). Ultra-long acting prodrug of dolutegravir and delivery system Physicochemical, pharmacokinetic and formulation characterizations. International Journal of Pharmaceutics. 120889.
    doi badge
  • Mohamed, E. M., Khuroo, T., Afrooz, H., Dharani, S., Sediri, K., Cook, P., ... Rahman, Z. (2020). Development of a Multivariate Predictive Dissolution Model for Tablets Coated with Cellulose Ester Blends.. Pharmaceuticals (Basel). 13(10), 311-311.
    doi badge pubmed badge
  • Barakh Ali, S. F., Dharani, S., Afrooz, H., Mohamed, E. M., Cook, P., Khan, M. A., & Rahman, Z. (2020). Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate.. AAPS PharmSciTech. 21(3), 99.
    doi badge pubmed badge
  • doi badge
  • Rahman, Z., Charoo, N. A., Kuttolamadom, M., Asadi, A., & Khan, M. A. (2020). Printing of personalized medication using binder jetting 3D printer. Precision Medicine for Investigators, Practitioners and Providers. 473-481. Elsevier.
    doi badge
  • Charoo, N. A., Rahman, Z., & Khan, M. A. (2019). Nanoparticles for improvement in oral bioavailability. Nanoarchitectonics in Biomedicine. 371-410. Elsevier.
    doi badge
  • Awotwe-Otoo, D., & Khan, M. (2019). Regulatory Aspects of Freeze-Drying. Methods in Pharmacology and Toxicology. 173-192. Springer New York.
    doi badge
  • Rahman, Z., Charoo, N. A., Akhter, S., Beg, S., Reddy, I. K., & Khan, M. A. (2018). Chapter 16 Nanotechnology-based drug products Science and regulatory considerations. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology. 619-655. Elsevier.
    doi badge
  • Mockus, L., LeBlond, D., Reklaitis, G. V., Basu, P. K., Paul, T., Pease, N., Nail, S. L., & Khan, M. A. (2018). Design Space Definition. Reklaitis, G. V., Seymour, C., & Garcia-Munoz, S. (Eds.), Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture. 301-318. John Wiley & Sons, Inc..
    doi badge
Conference Papers26
  • Funkhouser, C., Barakh Ali, S. F., Richardson, L., Rahman, Z., Khan, M., & Kuttolamadom, M. (2020). Thermal Influence on Printlet Quality in the Selective Laser Sintering of Pharmaceutical Formulations. Volume 1: Additive Manufacturing; Advanced Materials Manufacturing; Biomanufacturing; Life Cycle Engineering; Manufacturing Equipment and Automation, ASME 2020 15th International Manufacturing Science and Engineering Conference.
    doi badge
  • doi badge pubmed badge
researcher on
First Name
Last Name